Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort

Published:2018-03-23 Issue:5 Volume:33 Page:771-782
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Simuni Tanya¹,Siderowf Andrew²,Lasch Shirley³,Coffey Chris S.⁴,Caspell-Garcia Chelsea⁴,Jennings Danna⁵,Tanner Caroline M.⁶,Trojanowski John Q.²,Shaw Leslie M.²,Seibyl John³,Schuff Norbert⁶,Singleton Andrew⁷,Kieburtz Karl⁸,Toga Arthur W.⁹,Mollenhauer Brit¹⁰,Galasko Doug¹¹,Chahine Lana M.²,Weintraub Daniel²,Foroud Tatiana¹²,Tosun Duygu⁶,Poston Kathleen¹³,Arnedo Vanessa¹⁴,Frasier Mark¹⁴,Sherer Todd¹⁴,Chowdhury Sohini¹⁴,Marek Kenneth³,

Affiliation:

1. Northwestern University; Chicago Illinois USA

2. University of Pennsylvania; Philadelphia Pennsylvania USA

3. Institute for Neurodegenerative Disorders; New Haven Connecticut USA

4. University of Iowa; Iowa City Iowa USA

5. Eli Lilly; Indianapolis Indiana USA

6. University of California; San Francisco California USA

7. National Institute on Aging; National Institutes of Health; Bethesda Maryland USA

8. Clinical Trials Coordination Center; University of Rochester; Rochester New York USA

9. University of Southern California; Los Angeles California USA

10. Paracelsus-Elena Klinik; Kassel Germany

11. University of California; San Diego California USA

12. Indiana University; Indianapolis Indiana USA

13. Stanford University Medical Center; Stanford California USA

14. Michael J Fox Foundation; New York NY USA

Funder

Biogen Idec

Lundbeck

Meso Scale Diagnostics

Bristol-Myers Squibb Foundation

UCB

Covance

Pfizer

F. Hoffmann-La Roche

AbbVie

Avid Radiopharmaceuticals

GlaxoSmithKline

Genentech

Merck

GE Healthcare

The Michael J. Fox Foundation for Parkinson's Research

Piramal

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference23 articles.

1. Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology;Miyasaki;Neurology,2002

2. A responsive outcome for Parkinson's disease neuroprotection futility studies;Elm;Ann Neurol,2005

3. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan;Goetz;Mov Disord,2007

4. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results;Goetz;Mov Disord,2008

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validating New Symptom Emergence as a Patient-Centric Outcome Measure for PD Clinical Trials;Parkinsonism & Related Disorders;2024-09

2. Clinical assessment and striatal dopaminergic activity in healthy controls and patients with Parkinson’s disease: a Bayesian approach;Annals of Nuclear Medicine;2024-08-27

3. Acceptability of digital health technologies in early Parkinson's disease: lessons from WATCH-PD;Frontiers in Digital Health;2024-08-26

4. Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early‐ to Mid‐Stage Parkinson's Disease Modification Trials;Movement Disorders Clinical Practice;2024-08-22

5. Exposure to household pesticides and Parkinson's disease in the Parkinson's Progression Markers Initiative cohort;Frontiers in Neurology;2024-08-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3